--- title: "Pre-market hot trades in US stocks: Bgin Blockchain pre-market down 8.63%; OFA pre-market down 8.12%" type: "News" locale: "en" url: "https://longbridge.com/en/news/295907464.md" description: "Bgin Blockchain pre-market down 8.63%; OFA pre-market down 8.12%; Capricor Therapeutics pre-market up 108.79%; Akanda pre-market up 82.63%; China Su Xuan Tang Pharmaceutical pre-market up 64.41%" datetime: "2026-08-14T08:54:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295907464.md) - [en](https://longbridge.com/en/news/295907464.md) - [zh-HK](https://longbridge.com/zh-HK/news/295907464.md) generator: "portal-rs" --- # Pre-market hot trades in US stocks: Bgin Blockchain pre-market down 8.63%; OFA pre-market down 8.12% **Popular Pre-Market Trades in US Stocks** Bgin Blockchain, down 8.63% in pre-market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. OFA down 8.12% in pre-market. OFA down 8.12% in pre-market. No significant news recently; trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news **Top Gainers in Pre-Market US Stocks** Capricor Therapeutics up 108.79% in pre-market. Based on recent key news: 1. On August 14, Capricor Therapeutics reported a net loss of $40.7 million for the second quarter, with an adjusted loss per share of $0.70 and zero revenue. Cash and cash equivalents decreased to $237.9 million, down from the previous quarter. The stock price fell 82.6% in the second quarter and 85.5% year-to-date. This financial performance has attracted market attention, leading to stock price volatility. 2. On August 14, Capricor Therapeutics was accused of violating blinding and protocols in the HOPE-3 trial, deviating from the statistical analysis plan, and creating a new SAP the day before data unblinding. This legal lawsuit increases the legal risks faced by the company, affecting the stock price. 3. On August 13, whistleblowers were encouraged to use the SEC Whistleblower Program to provide non-public information to assist in the investigation. This move may lead to further legal actions, increasing market uncertainty. The biotechnology industry faces regulatory challenges, and capital flows are significant. Akanda up 82.63% in pre-market. Based on recent news: 1. On August 13, Akanda Corporation released new company content, driving the stock price up. The content published through Newsfile shows its positive developments in the market, attracting investor attention and leading to a significant pre-market increase of 82.63%; 2. On August 14, Akanda's market capitalization was approximately $2.71 million, with the stock price close to its annual low. Despite a 94.80% decline in stock price over the past 12 months, recent positive news has led investors to have optimistic expectations for its future performance, driving the stock price up; 3. On August 14, technical analysis showed Akanda's relative strength index at 29.27, indicating that its stock is technically oversold. This technical indicator may prompt investors to believe there is room for a rebound in the stock price, increasing buying interest. Market volatility is intensifying, and risks need to be monitored. China Su Xuan Tang Pharmaceutical up 64.41% in pre-market. Based on recent news: 1. On August 11, China Su Xuan Tang Pharmaceutical announced a 1-for-80 reverse stock split to meet Nasdaq's minimum bid requirements. This move has attracted market attention, driving the stock price significantly up On August 11, China Su Xuan Tang Pharmaceutical conducted a direct issuance of several million dollars in early 2026, while attempting to integrate AI analysis into its R&D pipeline. This move boosted investor confidence and further drove up the stock price. The traditional Chinese medicine industry has recently performed strongly, with significant capital inflows ### Related Stocks - [BGIN.US](https://longbridge.com/en/quote/BGIN.US.md) - [OFAL.US](https://longbridge.com/en/quote/OFAL.US.md) - [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md) - [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md) - [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md) ## Related News & Research - [Akanda wins Nasdaq extension to regain compliance with $2.5 million stockholders’ equity rule](https://longbridge.com/en/news/296145017.md) - [Rocketfuel Blockchain completes sale of RPay business to RPay](https://longbridge.com/en/news/296651295.md) - [The 30-Year Treasury Now Out-Yields Dividend Stocks by 2.2 Points. History Says What Followed the Last Time.](https://longbridge.com/en/news/296688720.md) - [The bond market is going to burst the stock-market bubble](https://longbridge.com/en/news/296527962.md) - [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**